Hopkins Announces Cancer Chemo Breakthrough

Monday, 18 Feb 2013 10:51 AM

By Nick Tate

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
In what is being hailed as a breakthrough in personalized cancer treatment, Johns Hopkins scientists have developed a way to custom-design chemotherapy drugs for cancer patients by using cell lines created from their own tumors.

The medical advance, published online in the journal Clinical Cancer Research, opens the door to better alternatives to current laboratory tests now used to optimize drug selection for patients — tests that have proven technically challenging, of limited use, and slow, the researchers said.

Anirban Maitra, a professor of pathology and oncology at the Johns Hopkins University School of Medicine, noted cancer specialists now typically choose chemotherapy drugs based on the affected organs' location or the appearance of tumors when viewed under a microscope. Some companies offer tests on removed tumors using a small number of anticancer drugs. But Maitra said the tissue samples used in such tests may have been affected by drugs or during shipment to a lab, compromising test results.

Editor's Note: Knowing these 5 cancer-causing signs is crucial to remaining cancer-free for life

"Our cell lines better and more accurately represent the tumors, and can be tested against any drug library in the world to see if the cancer is responsive," he said, explaining how the new Johns Hopkins technique can more accurately predict which drugs will be most effective for particular patients.

The Johns Hopkins scientists developed their cell lines by injecting human pancreatic and ovarian tumor cells into mice genetically engineered to grow tumors. The researchers then treated the tumors with a variety of drugs to see which ones would best destroy the cells.

By using the technique, the team was able to identify two anticancer drugs — from among more than 3,000 — that were the most effective in killing the tumors.
The study was funded, in part, by the National Institutes of Health.

© 2014 NewsmaxHealth. All rights reserved.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

New Ovarian Cancer Drug Gets FDA OK

Friday, 19 Dec 2014 15:48 PM

The U.S. Food and Drug Administration has approved a new drug to treat advanced ovarian cancer, along with a test to ide . . .

'Surveillance' Best Approach for Low-Risk Prostate Cancer: Study

Friday, 19 Dec 2014 12:39 PM

Among men whose low-risk prostate cancer was managed with so-called active surveillance for up to 15 years, just 1.5 per . . .

E-Cigs Less Addictive Than Regular Cigarettes, Say Researchers

Friday, 19 Dec 2014 12:35 PM

Former tobacco smokers find e-cigarettes less addictive than traditional cigarettes, new research finds. Even though the . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved